Rituxan (rituximab) - Roche
mycophenolate mofetil - Generic mfg.
Fulminant Seronegative Lupus Nephritis and the Challenge of Kidney Biopsy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0778; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Despite treatment with high-dose corticosteroids and mycophenolate mofetil, her renal and hemodynamic status worsened, requiring transfer to a tertiary care center for plasmapheresis and rituximab therapy. This case highlights the challenging balance between procedural risks of renal biopsy in medically complex patients and consequences of delayed recognition of aggressive lupus nephritis. Negative serology should not exclude lupus nephritis when clinical suspicion for immune-mediated glomerular disease is high." 
Biopsy • Cardiovascular • Chronic Kidney Disease • Cough • Genetic Disorders • Glomerulonephritis • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Obesity • Pulmonary Disease • Renal Disease • Respiratory Diseases • Systemic Lupus Erythematosus
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4560477
 
Luisa Fernanda Gomez Montoya; Krystal Simono; Nikhil Sai Jagarlamudi; Bhavana Nelakuditi
 
Oct 2, 2026
 
Prev Next